IL104314A0 - Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them - Google Patents

Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them

Info

Publication number
IL104314A0
IL104314A0 IL104314A IL10431493A IL104314A0 IL 104314 A0 IL104314 A0 IL 104314A0 IL 104314 A IL104314 A IL 104314A IL 10431493 A IL10431493 A IL 10431493A IL 104314 A0 IL104314 A0 IL 104314A0
Authority
IL
Israel
Prior art keywords
phe
cys
gly
glu
protease inhibitor
Prior art date
Application number
IL104314A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL104314A0 publication Critical patent/IL104314A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL104314A 1992-01-07 1993-01-06 Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them IL104314A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK9200003 1992-01-07

Publications (1)

Publication Number Publication Date
IL104314A0 true IL104314A0 (en) 1993-05-13

Family

ID=8153772

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104314A IL104314A0 (en) 1992-01-07 1993-01-06 Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US5618696A (de)
EP (1) EP0621873B1 (de)
JP (1) JP3345420B2 (de)
KR (1) KR940703860A (de)
AT (1) ATE171712T1 (de)
AU (1) AU670059B2 (de)
CA (1) CA2127247A1 (de)
CZ (1) CZ164894A3 (de)
DE (1) DE69321342T2 (de)
ES (1) ES2123635T3 (de)
FI (1) FI943235A0 (de)
HU (1) HUT70291A (de)
IL (1) IL104314A0 (de)
NO (1) NO942553L (de)
NZ (1) NZ246571A (de)
WO (1) WO1993014123A1 (de)
ZA (1) ZA9394B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134087A1 (en) * 1988-09-02 2006-06-22 Dyax Corp. ITI-D1 Kunitz domain mutants as hNE inhibitors
US5663143A (en) * 1988-09-02 1997-09-02 Dyax Corp. Engineered human-derived kunitz domains that inhibit human neutrophil elastase
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US5795954A (en) * 1994-03-04 1998-08-18 Genentech, Inc. Factor VIIa inhibitors from Kunitz domain proteins
US5780265A (en) * 1995-06-05 1998-07-14 Genentech, Inc. Kunitz type plasma kallikrein inhibitors
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
US6242414B1 (en) 1995-06-07 2001-06-05 Chiron Corporation Regulation of cytokine synthesis and release
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
PT2311432E (pt) 2002-06-07 2015-02-09 Dyax Corp Polipeptídeos de domínio kunitz modificado e sua utilização para a redução de isquemia ou aparecimento de uma resposta inflamatória sistémica associada a um procedimento cirúrgico
AU2004204095B2 (en) * 2003-01-07 2009-07-30 Dyax Corporation Kunitz domain library
CA2573368A1 (en) * 2004-07-13 2006-02-16 Bayer Pharmaceuticals Corporation Improved aprotinin variants
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
SI1981519T1 (en) 2005-12-29 2018-05-31 Dyax Corp. INHIBITION PROTEAZE
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
CN101952309A (zh) * 2007-12-21 2011-01-19 Ifxa有限公司 蛋白酶抑制剂
ES2773766T3 (es) 2008-12-19 2020-07-14 Baxalta GmbH Inhibidores de TFPI y métodos de uso
AU2010203712A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
LT2521568T (lt) * 2010-01-06 2018-12-10 Dyax Corp. Plazmos kalikreiną surišantys baltymai
AU2011227714B2 (en) 2010-03-19 2014-09-04 Takeda Pharmaceutical Company Limited TFPI inhibitors and methods of use
CN105713092B (zh) 2011-01-06 2019-09-10 戴埃克斯有限公司 血浆前激肽释放酶结合蛋白
CA2867363C (en) 2012-03-21 2023-02-28 Baxter International Inc. Tfpi inhibitors and methods of use
KR102555955B1 (ko) 2014-03-27 2023-07-18 다케다 파머수티컬 컴패니 리미티드 당뇨병성 황반 부종의 치료를 위한 조성물 및 방법
AU2016366557B2 (en) 2015-12-11 2024-01-25 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
EP3468605A4 (de) 2016-06-08 2020-01-08 President and Fellows of Harvard College Manipulierter viraler vektor zur reduzierung von induktion von entzündungs- und immunreaktionen
WO2019094548A1 (en) 2017-11-08 2019-05-16 President And Fellows Of Harvard College Compositions and methods for inhibiting viral vector-induced inflammatory responses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
DE3724570A1 (de) * 1987-06-27 1989-01-05 Bayer Ag Human-aprotinin, dessen lys-rest in position 15 gegen einen anderen protogenen aminosaeurerest ausgetauscht ist
US5106833A (en) * 1987-07-23 1992-04-21 Washington University Coagulation inhibitors
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
JPH07102137B2 (ja) * 1988-07-19 1995-11-08 塩野義製薬株式会社 修飾ヒトpsti

Also Published As

Publication number Publication date
NZ246571A (en) 1996-09-25
WO1993014123A1 (en) 1993-07-22
KR940703860A (ko) 1994-12-12
ZA9394B (en) 1993-08-10
CA2127247A1 (en) 1993-07-22
CZ164894A3 (en) 1994-12-15
AU3346193A (en) 1993-08-03
NO942553D0 (no) 1994-07-06
JP3345420B2 (ja) 2002-11-18
HU9401989D0 (en) 1994-09-28
ES2123635T3 (es) 1999-01-16
AU670059B2 (en) 1996-07-04
US5618696A (en) 1997-04-08
DE69321342T2 (de) 1999-04-01
EP0621873B1 (de) 1998-09-30
ATE171712T1 (de) 1998-10-15
HUT70291A (en) 1995-09-28
DE69321342D1 (de) 1998-11-05
FI943235A (fi) 1994-07-06
NO942553L (no) 1994-09-07
EP0621873A1 (de) 1994-11-02
JPH07504652A (ja) 1995-05-25
FI943235A0 (fi) 1994-07-06

Similar Documents

Publication Publication Date Title
IL104314A0 (en) Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
EP1531791A4 (de) PRûVENTION UND VERRINGERUNG VON BLUTVERLUST
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
IL104325A (en) Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
MD1652G2 (ro) Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
YU29596A (sh) Genski proizvodi koji regulišu gojaznost
CA2002924A1 (en) Anti-Thrombins
CA2083837A1 (en) Recombinant dna coding for a novel protein having .beta.-1,3 glucanase activity, bacteria containing this dna, transformed plant cells and plants
NZ334714A (en) Liver proteins as agents against autoimmune diseases
CA2077590A1 (en) Recombinant dna coding for a protein with endochitinase activity
AU585167B2 (en) Novel substrate peptides
AU8302791A (en) Recombinant gene coding for a protein having an endochitinase activity
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция
WO1999057262A3 (de) An metallionen bindendes peptid
EP1225184A4 (de) Menschliche antithrombin-varianten
PT100299A (pt) Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos